Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caicun Zhou

Showing results (1-10 of 549) with videos related to

Pageof 55
Sort By:
Translational Lung Cancer Research|March 26, 2015
Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapyCaicun Zhou
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 29, 2015
[Blood-based Tumor Markers in Lung Cancer]Caicun Zhou
Translational Lung Cancer Research|March 26, 2015
Lung cancer molecular epidemiology in China: recent trendsCaicun Zhou
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 23, 2011
[Current status and future direction of multi-targeted drugs in the era of personalized therapy--overview of advances in multi-targeted therapy in non-small cell lung cancer]Caicun Zhou
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 24, 2010
[Molecular diagnostics and molecular prognosis in lung cancer.]Caicun Zhou
Biochemical and Biophysical Research Communications|January 23, 2018
Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axisHongyu Wu, Caicun Zhou
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Chemotherapy Should Be Combined With Checkpoint Inhibitors in the Treatment of Patients With Stage IV EGFR-Mutant NSCLC Whose Disease Has Progressed on All Available Tyrosine Kinase InhibitorsFei Zhou, Caicun Zhou
Frontiers in Immunology|June 18, 2025
Integrated pan-cancer analysis of ADM's role in prognosis, immune modulation and resistanceYunhuan Liu, Caicun Zhou
Current Opinion in Oncology|November 12, 2025
Antibody-drug conjugates in lung cancer: current landscape and future perspectivesXinru Chen, Caicun Zhou
Translational Lung Cancer Research|December 21, 2019
Tyrosine kinase inhibitors interstitial pneumonitis: diagnosis and managementYayi He, Caicun Zhou
Pageof 55

Showing results (1-10 of 549) with videos related to

Sort By:
Pageof 55
Translational Lung Cancer Research|March 26, 2015
Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapyCaicun Zhou
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 29, 2015
[Blood-based Tumor Markers in Lung Cancer]Caicun Zhou
Translational Lung Cancer Research|March 26, 2015
Lung cancer molecular epidemiology in China: recent trendsCaicun Zhou
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 23, 2011
[Current status and future direction of multi-targeted drugs in the era of personalized therapy--overview of advances in multi-targeted therapy in non-small cell lung cancer]Caicun Zhou
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 24, 2010
[Molecular diagnostics and molecular prognosis in lung cancer.]Caicun Zhou
Biochemical and Biophysical Research Communications|January 23, 2018
Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axisHongyu Wu, Caicun Zhou
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Chemotherapy Should Be Combined With Checkpoint Inhibitors in the Treatment of Patients With Stage IV EGFR-Mutant NSCLC Whose Disease Has Progressed on All Available Tyrosine Kinase InhibitorsFei Zhou, Caicun Zhou
Frontiers in Immunology|June 18, 2025
Integrated pan-cancer analysis of ADM's role in prognosis, immune modulation and resistanceYunhuan Liu, Caicun Zhou
Current Opinion in Oncology|November 12, 2025
Antibody-drug conjugates in lung cancer: current landscape and future perspectivesXinru Chen, Caicun Zhou
Translational Lung Cancer Research|December 21, 2019
Tyrosine kinase inhibitors interstitial pneumonitis: diagnosis and managementYayi He, Caicun Zhou
Pageof 55